• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
BIOALVO S.A. - Product Pipeline Review - Q4 2010 Product Image

BIOALVO S.A. - Product Pipeline Review - Q4 2010

  • Published: November 2010
  • 29 pages
  • GlobalData

BIOALVO S.A. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “BIOALVO S.A. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- BIOALVO S.A. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of BIOALVO S.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- READ MORE >



List of Tables
List of Figures
BIOALVO S.A. Snapshot
BIOALVO S.A. Overview
Key Information
Key Facts
BIOALVO S.A. – Research and Development Overview
Key Therapeutic Areas
BIOALVO S.A. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
BIOALVO S.A. – Pipeline Products Glance
BIOALVO S.A.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
BIOALVO S.A. – Drug Profiles
BLV200703
Product Description
Mechanism of Action
R&D Progress
BLV200704
Product Description
Mechanism of Action
R&D Progress
SDGI-T200801
Product Description
Mechanism of Action
R&D Progress
SLBK200801
Product Description
Mechanism of Action
R&D Progress
SDGI-CF200801
Product Description
Mechanism of Action
R&D Progress
SDGI-TT200801
Product Description
Mechanism of Action
R&D Progress
SDGII-T200801
Product Description
Mechanism of Action
R&D Progress
BIOALVO S.A. – Pipeline Analysis
BIOALVO S.A. – Pipeline Products by Therapeutic Class
BIOALVO S.A. Pipeline Products By Target
BIOALVO S.A. – Pipeline Products by Molecule Type
BIOALVO S.A. - Dormant Projects
BIOALVO S.A. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Oct 29, 2008: Portuguese Researchers Lead International Consortium Develops Novel Clinical Drug, BLV200704
Oct 29, 2008: Portuguese Researchers Lead International Consortium Develops Novel Clinical Drug, BLV200704
Financial Deals Landscape
BIOALVO S.A., Deals Summary, 2004 to 2010
BIOALVO S.A. Detailed Deal Summary
Marinomed Biotechnologie Enters Into Agreement With BIOALVO
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS